These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 28934284)
1. Correlation of DAPK1 methylation and the risk of gastrointestinal cancer: A systematic review and meta-analysis. Yuan W; Chen J; Shu Y; Liu S; Wu L; Ji J; Liu Z; Tang Q; Zhou Z; Cheng Y; Jiang B; Shu X PLoS One; 2017; 12(9):e0184959. PubMed ID: 28934284 [TBL] [Abstract][Full Text] [Related]
2. Association between DAPK1 promoter methylation and cervical cancer: a meta-analysis. Xiong J; Li Y; Huang K; Lu M; Shi H; Ma L; Luo A; Yang S; Lu Z; Zhang J; Yang L; Wang S PLoS One; 2014; 9(9):e107272. PubMed ID: 25268905 [TBL] [Abstract][Full Text] [Related]
3. DAPK1 Promoter Methylation and Cervical Cancer Risk: A Systematic Review and a Meta-Analysis. Agodi A; Barchitta M; Quattrocchi A; Maugeri A; Vinciguerra M PLoS One; 2015; 10(8):e0135078. PubMed ID: 26267895 [TBL] [Abstract][Full Text] [Related]
4. Association of Protein Expression and Methylation of DAPK1 with Clinicopathological Features in Invasive Ductal Carcinoma Patients from Kashmir. Asiaf A; Ahmad ST; Malik AA; Aziz SA; Zargar MA Asian Pac J Cancer Prev; 2019 Mar; 20(3):839-848. PubMed ID: 30912402 [TBL] [Abstract][Full Text] [Related]
5. Hypermethylation of Death-Associated Protein Kinase (DAPK1) and its association with oral carcinogenesis - An experimental and meta-analysis study. Jayaprakash C; Varghese VK; Bellampalli R; Radhakrishnan R; Ray S; Kabekkodu SP; Satyamoorthy K Arch Oral Biol; 2017 Aug; 80():117-129. PubMed ID: 28412611 [TBL] [Abstract][Full Text] [Related]
6. Promoter Methylation of BRCA1, DAPK1 and RASSF1A is Associated with Increased Mortality among Indian Women with Breast Cancer. Yadav P; Masroor M; Nandi K; Kaza RCM; Jain SK; Khurana N; Saxena A Asian Pac J Cancer Prev; 2018 Feb; 19(2):443-448. PubMed ID: 29480000 [TBL] [Abstract][Full Text] [Related]
7. Aberrant methylation and expression of DAPk1 in human hypopharyngeal squamous cell carcinoma. Wei DM; Liu DY; Lei DP; Jin T; Wang J; Pan XL Acta Otolaryngol; 2015 Jan; 135(1):70-8. PubMed ID: 25496179 [TBL] [Abstract][Full Text] [Related]
8. Epigenetic inactivation of DAPK1, p14ARF, mir-34a and -34b/c in acute promyelocytic leukaemia. Ng HY; Wan TS; So CC; Chim CS J Clin Pathol; 2014 Jul; 67(7):626-31. PubMed ID: 24811488 [TBL] [Abstract][Full Text] [Related]
9. Quantification of DAPK1 promoter methylation in bone marrow and peripheral blood as a follicular lymphoma biomarker. Giachelia M; Bozzoli V; D'Alò F; Tisi MC; Massini G; Maiolo E; Guidi F; Cupelli E; Martini M; Larocca LM; Voso MT; Leone G; Hohaus S J Mol Diagn; 2014 Jul; 16(4):467-76. PubMed ID: 24814955 [TBL] [Abstract][Full Text] [Related]
10. Identification of methylation markers for the prediction of nodal metastasis in oral and oropharyngeal squamous cell carcinoma. Melchers LJ; Clausen MJ; Mastik MF; Slagter-Menkema L; van der Wal JE; Wisman GB; Roodenburg JL; Schuuring E Epigenetics; 2015; 10(9):850-60. PubMed ID: 26213212 [TBL] [Abstract][Full Text] [Related]
11. Clinical effect of DAPK promoter methylation in gastric cancer: A systematic meta-analysis. Jia W; Yu T; Cao X; An Q; Yang H Medicine (Baltimore); 2016 Oct; 95(43):e5040. PubMed ID: 27787359 [TBL] [Abstract][Full Text] [Related]
12. DAPK promoter methylation status correlates with tumor metastasis and poor prognosis in patients with non-small cell lung cancer. Zhang J; Yu XL; Zheng GF; Zhao F Cancer Biomark; 2015; 15(5):609-17. PubMed ID: 26406950 [TBL] [Abstract][Full Text] [Related]
13. Development of a multiplex MethyLight assay for the detection of DAPK1 and SOX1 methylation in epithelial ovarian cancer in a north Indian population. Kaur M; Singh A; Singh K; Gupta S; Sachan M Genes Genet Syst; 2016 Nov; 91(3):175-181. PubMed ID: 27452040 [TBL] [Abstract][Full Text] [Related]
14. DAPK Promoter Methylation and Bladder Cancer Risk: A Systematic Review and Meta-Analysis. Dai L; Ma C; Zhang Z; Zeng S; Liu A; Tang S; Ren Q; Sun Y; Xu C PLoS One; 2016; 11(12):e0167228. PubMed ID: 27907054 [TBL] [Abstract][Full Text] [Related]
15. Relationships between p16 gene promoter methylation and clinicopathologic features of colorectal cancer: a meta-analysis of 27 cohort studies. Chen YZ; Liu D; Zhao YX; Wang HT; Gao Y; Chen Y DNA Cell Biol; 2014 Oct; 33(10):729-38. PubMed ID: 24979649 [TBL] [Abstract][Full Text] [Related]
16. Relationship between epithelial cell adhesion molecule (EpCAM) overexpression and gastric cancer patients: A systematic review and meta-analysis. Dai M; Yuan F; Fu C; Shen G; Hu S; Shen G PLoS One; 2017; 12(4):e0175357. PubMed ID: 28403178 [TBL] [Abstract][Full Text] [Related]
17. The prognostic value of DAPK1 hypermethylation in gliomas: A site-specific analysis. Li X; Pu J; Liu J; Chen Y; Li Y; Hou P; Shi B; Yang Q Pathol Res Pract; 2018 Jul; 214(7):940-948. PubMed ID: 29807777 [TBL] [Abstract][Full Text] [Related]
18. Promoter methylation of DAPK gene may contribute to the pathogenesis of nonsmall cell lung cancer: a meta-analysis. Li FF; Yang Y; Wang XL; Hong YY; Wang NF; Chen ZD Tumour Biol; 2014 Jun; 35(6):6011-20. PubMed ID: 24659425 [TBL] [Abstract][Full Text] [Related]
19. BNIP3 and DAPK1 methylation in peripheral blood leucocytes are noninvasive biomarkers for gastric cancer. Wang F; Hu D; Lou X; Wang Y; Wang L; Zhang T; Yan Z; Meng N; Zou Y Gene; 2024 Mar; 898():148109. PubMed ID: 38142898 [TBL] [Abstract][Full Text] [Related]
20. Association of aberrant DNA methylation with clinicopathological features in breast cancer. Tserga A; Michalopoulos NV; Levidou G; Korkolopoulou P; Zografos G; Patsouris E; Saetta AA Oncol Rep; 2012 May; 27(5):1630-8. PubMed ID: 22159596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]